| |
|
|
|
CfPA - The Center for Professional Advancement, Burlingame, CA
February 8, 2012
Who Should Attend
This course will be valuable to professionals employed in the Pharmaceutical, Cosmetic and Personal Care industry especially those involved in topically applied product development. In addition, individuals working in the following areas will benefit from this intensive one-day course:
• Dermatology community and related industries
• Professionals in hospitals that work on topical chemicals
exposure
• Professionals in regulatory institutions that work on dermal
exposure Description
The Pharmaceutical and Cosmetic and Personal Care industry both face challenges of developing topically applied formulations that present no adverse reactions when applied to skin. This one day course is designed to explain the different reactions possible, their cause, biochemistry and prevention.
Save $300 off combined regular tuition!
Attend this course and its companion course:
Claim Substantiation for Clinical Studies of Cosmetic Products, February 6-7, 2012, Course ID #2398
|
|
|
|
|
|
|
|
Organized by:
|
|
CfPA - The Center for Professional Advancement |
|
|
Invited Speakers:
|
|
Nava Dayan, Ph.D.; Skin Care Research Expert
Dr. Dayan earned her Ph.D. in Pharmaceutics from the Hebrew University in Jerusalem specializing in skin delivery. She is currently an Associate Adjunct Professor in the Ernest Mario School of Pharmacy at Rutgers University, and the Research and Development and Safety Assessment Director at Lipo Chemicals Inc. During her 24 years of experience she has specialized in a variety of areas related to skin treatment:
• The research and understanding of the interaction between topically applied
compounds and the skin
• Findings in skin biochemistry and especially the upper layer of the skin–
the stratum corneum
• Delivery of active compounds into and through the skin and the development of delivery
systems to facilitate transport, improve bio-availability and reduce toxicity
• Design and development of topically applied formulations
• Design of clinical studies to substantiate market claims and to assure safety
• Academic teaching and lecturing
• Industrial experience in both development of active compounds, delivery systems and
finished formulations
• Skin absorption studies in vivo and in vitro for safety/efficacy assessment
• In vitro methodologies for safety assessment of topically applied compounds
Dr. Dayan has received numerous awards of excellence for papers she has authored. She has recently published 2 books, entitled… Formulating, Packaging, and Marketing of Natural Cosmetic Products and Innate Immune System of Skin and Oral Mucos and is author or co-author more then 80 publications. Dr. Dayan is a member of the Dermatopharmaceutics Focus Group, the Abstract Review Committee for the American Association of Pharmaceutical Scientists (AAPS), and the Consumer Products Group of the International Controlled Release Society (CRS). She is also a member of the US Society of Cosmetic Chemists, and the chair of the Annual Cosmeceuticals Summit Symposium. Dr. Dayan teaches at Rutgers University and Directs many other courses at the Center for Professional Advancement.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
n/a
|
|
|
|
|
|
|
|
Registration:
|
|
Please click here for registration information.
|
|
|
E-mail:
|
|
sberg@cfpa.com
|
|
|
|
|
|
|
|
|